{"nct_id":"NCT03189719","title":"First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)","status":"COMPLETED","status_verified_date":"2024-10","start_date":"2017-07-25","start_date_type":"ACTUAL","primary_completion_date":"2020-07-02","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}